rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
8
|
pubmed:dateCreated |
1998-8-27
|
pubmed:abstractText |
Small case series have reported potential benefit from thrombolysis after spontaneous intraventricular hemorrhage (IVH). Our objective was to review our experience using intraventricular urokinase (UK) in treating selected patients with IVH.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0039-2499
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
29
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1573-9
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:9707195-Adult,
pubmed-meshheading:9707195-Aged,
pubmed-meshheading:9707195-Aged, 80 and over,
pubmed-meshheading:9707195-Cerebral Hemorrhage,
pubmed-meshheading:9707195-Cerebral Ventricles,
pubmed-meshheading:9707195-Cohort Studies,
pubmed-meshheading:9707195-Combined Modality Therapy,
pubmed-meshheading:9707195-Female,
pubmed-meshheading:9707195-Glasgow Coma Scale,
pubmed-meshheading:9707195-Humans,
pubmed-meshheading:9707195-Injections, Intraventricular,
pubmed-meshheading:9707195-Male,
pubmed-meshheading:9707195-Middle Aged,
pubmed-meshheading:9707195-Plasminogen Activators,
pubmed-meshheading:9707195-Prognosis,
pubmed-meshheading:9707195-Thrombolytic Therapy,
pubmed-meshheading:9707195-Treatment Outcome,
pubmed-meshheading:9707195-Urokinase-Type Plasminogen Activator,
pubmed-meshheading:9707195-Ventriculostomy
|
pubmed:year |
1998
|
pubmed:articleTitle |
A cohort study of the safety and feasibility of intraventricular urokinase for nonaneurysmal spontaneous intraventricular hemorrhage.
|
pubmed:affiliation |
Department of Neurological Surgery, Detroit Receiving and Grace Hospitals, Wayne State University, Mich 48201, USA. wcoplin@med.wayne.edu
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|